{
    "ticker": "JANW",
    "name": "JanOne Inc.",
    "description": "JanOne Inc. is a biopharmaceutical company dedicated to developing innovative solutions for pain management and improving the quality of life for patients suffering from chronic pain. Founded in 2018, JanOne is focused on utilizing its proprietary technology to address the unmet needs in the pain and addiction markets. The company's lead product candidate, JAN101, is designed to be a non-opioid treatment for patients suffering from pain, providing a safer alternative to traditional opioid therapies. JanOne aims to revolutionize the treatment of pain through a unique approach that combines cutting-edge science and patient-centric solutions. In addition to its drug development efforts, JanOne is committed to raising awareness about the opioid crisis and promoting responsible pain management practices. The company is also exploring partnerships and collaborations with other organizations to enhance its research capabilities and expand its reach in the healthcare industry. With a strong focus on research and development, JanOne is poised to make significant strides in the field of pain management and improve outcomes for patients worldwide.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Las Vegas, Nevada, USA",
    "founded": "2018",
    "website": "https://www.janone.com",
    "ceo": "Dr. Tony Mazzulla",
    "social_media": {
        "twitter": "https://twitter.com/JanOneInc",
        "linkedin": "https://www.linkedin.com/company/janone-inc/"
    },
    "investor_relations": "https://www.janone.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Tony Mazzulla",
            "position": "CEO"
        },
        {
            "name": "David J. DeNero",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "JAN101"
            ]
        }
    ],
    "seo": {
        "meta_title": "JanOne Inc. | Innovative Solutions for Pain Management",
        "meta_description": "JanOne Inc. is at the forefront of developing non-opioid pain management solutions. Discover our commitment to improving patient care and addressing the opioid crisis.",
        "keywords": [
            "JanOne",
            "Pain Management",
            "Biopharmaceutical",
            "Non-Opioid Therapy",
            "Chronic Pain"
        ]
    },
    "faq": [
        {
            "question": "What is JanOne known for?",
            "answer": "JanOne is known for developing innovative non-opioid pain management therapies."
        },
        {
            "question": "Who is the CEO of JanOne?",
            "answer": "Dr. Tony Mazzulla is the CEO of JanOne Inc."
        },
        {
            "question": "Where is JanOne headquartered?",
            "answer": "JanOne is headquartered in Las Vegas, Nevada, USA."
        },
        {
            "question": "What is JAN101?",
            "answer": "JAN101 is JanOne's lead product candidate aimed at providing a non-opioid treatment for pain."
        },
        {
            "question": "When was JanOne founded?",
            "answer": "JanOne was founded in 2018."
        }
    ],
    "competitors": [
        "PFE",
        "AMGN",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "MRK",
        "GILD",
        "BMY"
    ]
}